-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Currently, doctors mainly rely on cognitive tests to diagnose whether a person has AD
At present, the research team led by Professor Nancy IP, Vice President of Research and Development of the Hong Kong University of Science and Technology, has identified 19 of the 429 AD-related plasma proteins to form biomarkers of the "AD fingerprint" in the blood
Professor Yeh, Professor of Life Sciences at the Hong Kong University of Science and Technology and Director of the State Key Laboratory of Molecular Neuroscience, said: "With the development of ultra-sensitive blood protein detection technology, we have developed a simple, non-invasive and accurate AD diagnosis program, which will greatly Promote population-scale disease screening and staging
The study was conducted in collaboration with researchers from University College London and clinicians from local hospitals (including Prince of Wales Hospital and Queen Elizabeth Hospital)
As the most comprehensive study of blood proteins in AD patients so far, the research results have recently been published in the journal Alzheimer's & Dementia , and special reports and active discussions have been carried out on different academic exchange platforms for Alzheimer's disease research
More than 50 million people worldwide are affected by AD, including brain cell dysfunction and loss
Original Search: Yuanbing Jiang, Xiaopu Zhou, Fanny C.